Our Research

Mbili Pamoja Month 12 Study Updates

As of 5th October 2025 a total of 220 participants had successfully completed their Month 12 study follow up visits, representing an 88% turnout. We have 30 participants remaining so that we can clear month 12 follow up.

Mbili Pamoja Study Staff Dissemination Report held on 12th August 2025

Mbili Pamoja Dissemination Report held on 12th August 2025 Facilitator-Felix Ochieng Note taker-Patriciah Wambua Venue-Anza Mapema Date-12th August 2025 Composition of the attendees. A total of 15 staff members participated in the dissemination. The team comprised: one receptionist/records officer, two HTS counsellors, a hygiene officer, a field officer, a

Mbili Pamoja Study Participants Dissemination Report Held on 22nd July 2025

Mbili Pamoja Dissemination Report held on 22nd July 2025 Facilitator-Felix Ochieng Note taker-Patriciah Wambua Venue-Anza Mapema Date-22nd July 2025 Description of attendees We reached out to a total of 200 participants, and 171 were able to attend the dissemination meeting. Mobilization was carried out through peer educators who played a

The AMKAJ 2 Study: Microbiome and Mucosal Immunology Among MSM Couples in Kenya

The Anza Mapema kwa Afya Jamii Mbili (AMKAJ 2) Study was a pilot investigation built on findings from the earlier AMKAJ 1 project to further investigate the biological factors contributing to HIV and STI vulnerability among men who have sex with men (MSM) in Kenya. This pilot study focused specifically

Shauriana Randomised Controlled Trial

Study Long Title: Acceptability, Feasibility, and Safety of the Shauriana Intervention for Young Kenyan Gay, Bisexual, and Other Men Who Have Sex with Men, and Exploration of Potential Impact on Sexual Health Outcomes Background: Gay, bisexual, and other men who have sex with men (GBMSM) in Kenya are at a

POWWeR Health Study

Background This single-arm trial seeks to evaluate the preliminary efficacy of menstrual cups on non-optimal vaginal microbiome (VMB), BV, and STIs of economically vulnerable women at high risk for STIs and HIV, and to understand safety, acceptability, and implementation needs. The goal of this study is to generate preliminary efficacy

FAST Research Study - Assessments of the efficacy, the Onset-of-Action and the Safety of Tot'héma® in adults with moderate Iron deficiency anemia

At Nyanza Reproductive Health Society (NRHS), we’re committed to improving the health and well-being of communities in Kenya. We’re currently involved in an exciting clinical trial, FAST, which evaluates the effectiveness and safety of Tot'héma®, an oral solution used to treat moderate iron deficiency anemia (IDA)